R Squared LTD Nuvectis Pharma, Inc. Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, R Squared LTD holds 310 shares of NVCT stock, worth $1,993. This represents 0.0% of its overall portfolio holdings.
Number of Shares
310Holding current value
$1,993% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVCT
# of Institutions
31Shares Held
1.83MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$3.62 Million5.37% of portfolio
-
Baldwin Brothers LLC356KShares$2.29 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA301KShares$1.94 Million0.0% of portfolio
-
Black Rock Inc. New York, NY83.4KShares$536,3390.0% of portfolio
-
Geode Capital Management, LLC Boston, MA79.7KShares$512,5730.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $94.2M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...